Informazioni sul prodotto
- 1H-3-Benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-, (±)-
- SKF 83566
- 1H-3-Benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-
- 8-Bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol
SKF-83566 is a selective dopamine D2 receptor antagonist that blocks the interaction of dopamine with its receptors in the brain. This drug has been shown to have an inhibitory effect on spontaneous motor activity and to interact with other dopamine receptors, such as the M1 receptor. SKF-83566 has been studied in rats and found to have an interactive effect on the d4 receptor and inhibiting adenylate cyclase activity. The clinical relevance of this drug is still being investigated, but it may be used for pharmacological treatment or for molecular probes.
Proprietà chimiche
Richiesta tecnica su: 3D-ZDA29533 SKF-83566
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
